From Molecular Biology to Targeted Therapies for Hepatocellular Carcinoma: The Future Is Now

Publisher： Karger

E-ISSN： 1423-0232|72|1|30-44

ISSN： 0030-2414

Source： Oncology, Vol.72, Iss.1, 2007-12, pp. : 30-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New molecularly targeted therapies against advanced hepatocellular carcinoma: From molecular pathogenesis to clinical trials and future directions

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 10, 2015-10 ,pp. : E1-E11

John Wiley & Sons Inc

Access to resources Recommend Favorite

Loco-Regional Treatment of Hepatocellular Carcinoma in the Era of Molecular Targeted Therapies

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 107-112

Karger

Access to resources Recommend Favorite

Management of Hepatocellular Carcinoma: From Prevention to Molecular Targeted Therapy

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Hepatocellular Carcinoma in 2011 and Beyond: From the Pathogenesis to Molecular Targeted Therapy

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 1-10

Karger

Access to resources Recommend Favorite

Hepatocellular Carcinoma 2009 and Beyond: from the Surveillance to Molecular Targeted Therapy

By  

Oncology, Vol. 75, Iss. 1, 2008-12 ,pp. : 1-12

Karger

Access to resources Recommend Favorite